OptimizeRx Corp Files 2025 Proxy Statement
Ticker: OPRX · Form: DEF 14A · Filed: Apr 30, 2025 · CIK: 1448431
| Field | Detail |
|---|---|
| Company | Optimizerx CORP (OPRX) |
| Form Type | DEF 14A |
| Filed Date | Apr 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance, shareholder-meeting
TL;DR
OptimizeRx proxy filed, shareholders vote on exec pay & board soon.
AI Summary
OptimizeRx Corp filed its definitive proxy statement on April 30, 2025, for its annual meeting on June 11, 2025. The filing details executive compensation, board nominations, and other corporate governance matters. Shareholders will vote on proposals presented by the company.
Why It Matters
This filing provides shareholders with crucial information to make informed voting decisions on company leadership and strategic direction.
Risk Assessment
Risk Level: low — This is a routine proxy filing providing information to shareholders and does not inherently present new risks.
Key Players & Entities
- OptimizeRx Corp (company) — Registrant
- 20250430 (date) — Filing Date
- 20250611 (date) — Meeting Date
FAQ
What is the purpose of this DEF 14A filing?
The purpose of this DEF 14A filing is to provide shareholders with information regarding the annual meeting of shareholders, including proposals to be voted on, executive compensation, and board nominations.
When is the OptimizeRx Corp annual meeting scheduled?
The annual meeting of shareholders for OptimizeRx Corp is scheduled for June 11, 2025.
What is the filing date of this proxy statement?
The definitive proxy statement was filed on April 30, 2025.
What type of company is OptimizeRx Corp?
OptimizeRx Corp is classified under SERVICES-BUSINESS SERVICES, NEC with SIC code 7389.
Where is OptimizeRx Corp headquartered?
OptimizeRx Corp's business and mailing address is 260 Charles Street, Suite 302, Waltham, MA 02453.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 30, 2025 regarding OptimizeRx Corp (OPRX).